These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 32091032

  • 1. Sustained effects of intralymphatic pollen-specific immunotherapy on Japanese cedar pollinosis.
    Terada T, Omura S, Kikuoka Y, Suzuki M, Inaka Y, Inui T, Matsuda M, Nabe T, Kawata R.
    Rhinology; 2020 Jun 01; 58(3):241-247. PubMed ID: 32091032
    [Abstract] [Full Text] [Related]

  • 2. Intralymphatic allergen-specific immunotherapy: an effective and safe alternative treatment route for pollen-induced allergic rhinitis.
    Hylander T, Latif L, Petersson-Westin U, Cardell LO.
    J Allergy Clin Immunol; 2013 Feb 01; 131(2):412-20. PubMed ID: 23374268
    [Abstract] [Full Text] [Related]

  • 3. Intralymphatic immunotherapy for mountain cedar pollinosis: A randomized, double-blind, placebo-controlled trial.
    Thompson CP, Silvers S, Shapiro MA.
    Ann Allergy Asthma Immunol; 2020 Sep 01; 125(3):311-318.e2. PubMed ID: 32407947
    [Abstract] [Full Text] [Related]

  • 4. [Lowered effectiveness of immunotherapy for cypress pollinosis by using Japanese cedar pollen extract].
    Horiguchi S, Okamoto Y, Yonekura S, Okawa T, Kunii N, Yamamoto H, Sakurai D, Hanazawa T.
    Arerugi; 2008 May 01; 57(5):558-61. PubMed ID: 18520178
    [Abstract] [Full Text] [Related]

  • 5. Clinical effects of immunotherapy on Japanese cedar pollinosis in the season of cedar and cypress pollination.
    Ito Y, Takahashi Y, Fujita T, Fukuyama S.
    Auris Nasus Larynx; 1997 Apr 01; 24(2):163-70. PubMed ID: 9134139
    [Abstract] [Full Text] [Related]

  • 6. Intralymphatic immunotherapy improves grass pollen allergic rhinoconjunctivitis: A 3-year randomized placebo-controlled trial.
    Skaarup SH, Schmid JM, Skjold T, Graumann O, Hoffmann HJ.
    J Allergy Clin Immunol; 2021 Mar 01; 147(3):1011-1019. PubMed ID: 32679209
    [Abstract] [Full Text] [Related]

  • 7. Intralymphatic immunotherapy of pollen-induced rhinoconjunctivitis: a double-blind placebo-controlled trial.
    Hylander T, Larsson O, Petersson-Westin U, Eriksson M, Kumlien Georén S, Winqvist O, Cardell LO.
    Respir Res; 2016 Jan 27; 17():10. PubMed ID: 26817454
    [Abstract] [Full Text] [Related]

  • 8. Allergen-specific subcutaneous immunotherapy for Japanese cedar pollinosis decreases the number of metachromatic cells and eosinophils in nasal swabs during the preseason and in season.
    Otsuka K, Otsuka H, Matsune S, Okubo K.
    Immun Inflamm Dis; 2020 Sep 27; 8(3):258-266. PubMed ID: 32239697
    [Abstract] [Full Text] [Related]

  • 9. Safety and efficacy of a new regimen of short-term oral immunotherapy with Cry j 1-galactomannan conjugate for Japanese cedar pollinosis: a prospective, randomized, open-label study.
    Murakami D, Sawatsubashi M, Kikkawa S, Ejima M, Saito A, Kato A, Komune S.
    Allergol Int; 2015 Apr 27; 64(2):161-8. PubMed ID: 25838092
    [Abstract] [Full Text] [Related]

  • 10. Safety and efficacy of short-term oral immunotherapy with Cry j 1-galactomannan conjugate for Japanese cedar pollinosis: a randomized controlled trial.
    Murakami D, Sawatsubashi M, Omori H, Saito A, Kato A, Komune S, Nakagawa T.
    Sci Rep; 2017 Apr 11; 7():46142. PubMed ID: 28397833
    [Abstract] [Full Text] [Related]

  • 11. Long-term sublingual immunotherapy provides better effects for patients with Japanese cedar pollinosis.
    Hamada S, Kobayashi Y, Sakamoto D, Shimamura A, Kuroda K, Kawachi R, Kanda A, Asako M, Gotoh M, Okubo K, Tomoda K, Iwai H.
    Auris Nasus Larynx; 2021 Aug 11; 48(4):646-652. PubMed ID: 33526319
    [Abstract] [Full Text] [Related]

  • 12. Effect of short-term oral immunotherapy with Cry j1-galactomannan conjugate on quality of life in Japanese cedar pollinosis patients: A prospective, randomized, open-label study.
    Murakami D, Sawatsubashi M, Kikkawa S, Ejima M, Saito A, Kato A, Komune S.
    Auris Nasus Larynx; 2016 Feb 11; 43(1):50-5. PubMed ID: 26197940
    [Abstract] [Full Text] [Related]

  • 13. Intralymphatic immunotherapy with birch and grass pollen extracts. A randomized double-blind placebo-controlled clinical trial.
    Ahlbeck L, Ahlberg E, Stuivers L, Björkander J, Nyström U, Retsas P, Govindaraj D, Jenmalm MC, Duchén K.
    Clin Exp Allergy; 2023 Aug 11; 53(8):809-820. PubMed ID: 37013723
    [Abstract] [Full Text] [Related]

  • 14. Japanese cedar and cypress pollinosis updated: New allergens, cross-reactivity, and treatment.
    Osada T, Okano M.
    Allergol Int; 2021 Jul 11; 70(3):281-290. PubMed ID: 33962864
    [Abstract] [Full Text] [Related]

  • 15. Efficacy and safety of sublingual immunotherapy for two seasons in patients with Japanese cedar pollinosis.
    Okamoto Y, Okubo K, Yonekura S, Hashiguchi K, Goto M, Otsuka T, Murata T, Nakao Y, Kanazawa C, Nagakura H, Okawa T, Nakano K, Hisamitsu M, Kaneko S, Konno A.
    Int Arch Allergy Immunol; 2015 Jul 11; 166(3):177-88. PubMed ID: 25895909
    [Abstract] [Full Text] [Related]

  • 16. Phase I/II study of oral immunotherapy with Cry j1-galactomannan conjugate for Japanese cedar pollinosis.
    Murakami D, Kubo K, Sawatsubashi M, Kikkawa S, Ejima M, Saito A, Kato A, Komune S.
    Auris Nasus Larynx; 2014 Aug 11; 41(4):350-8. PubMed ID: 24698163
    [Abstract] [Full Text] [Related]

  • 17. A randomized controlled trial of sublingual immunotherapy for Japanese cedar pollinosis.
    Horiguchi S, Okamoto Y, Yonekura S, Okawa T, Yamamoto H, Kunii N, Sakurai D, Fujimura T, Nakazawa K, Yasueda H.
    Int Arch Allergy Immunol; 2008 Aug 11; 146(1):76-84. PubMed ID: 18087165
    [Abstract] [Full Text] [Related]

  • 18. Identification of Cha o 3 homolog Cry j 4 from Cryptomeria japonica (Japanese cedar) pollen: Limitation of the present Japanese cedar-specific ASIT.
    Osada T, Tanaka Y, Yamada A, Sasaki E, Utsugi T.
    Allergol Int; 2018 Oct 11; 67(4):467-474. PubMed ID: 29525489
    [Abstract] [Full Text] [Related]

  • 19. [INVESTIGATION OF TREATMENT GOAL IN ALLERGEN IMMUNOTHERAPY FOR JAPANESE CEDAR POLLINOSIS].
    Gotoh M, Okubo K, Okamoto Y, Yonekura S, Kaneko S, Konno A.
    Arerugi; 2018 Oct 11; 67(7):938-947. PubMed ID: 30146626
    [Abstract] [Full Text] [Related]

  • 20. A 5-Year Open-Label Follow-up of a Randomized Double-Blind Placebo-Controlled Trial of Intralymphatic Immunotherapy for Birch and Grass Allergy Reveals Long-term Beneficial Effects.
    Hjalmarsson E, Hellkvist L, Karlsson A, Winquist O, Kumlien Georén S, Westin U, Cardell LO.
    J Investig Allergol Clin Immunol; 2023 Oct 11; 33(5):362-372. PubMed ID: 37843385
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.